Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Anticancer Research|January 1, 1990
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancerM Giai, C Natoli, P Sismondi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Serum total and free prostate-specific antigen for breast cancer diagnosis in womenM H Black, M Giai, R Ponzone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1989
Complications of uterine cervix carcinoma treatments: the problem of a uniform classificationP Sismondi, G Sinistrero, P Zola, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2005
The influence of hormone replacement therapy on the pathology of breast cancerN Biglia, L Sgro, E Defabiani, et al.
Acta Europaea Fertilitatis|November 1, 1991
Transvaginal salpingo-sonography (TSSG) in the evaluation of tubal patencyE Volpi, T De Grandis, P Sismondi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 7, 2003
Sentinel node dissection as definitive treatment for node negative breast cancer patientsR Ponzone, N Biglia, F Maggiorotto, et al.
Maturitas|September 7, 2005
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivorsN Biglia, Riccardo Torta, R Roagna, et al.
International Journal of Oncology|May 17, 2011
Avm (adriamycin, vinblastine, methotrexate) neoadjuvant chemotherapy in advanced or inflammatory carcinoma of the breastP Zola, G Schnapper, D Katsaros, et al.
British Journal of Cancer|May 3, 2002
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancerA Chang, G M Yousef, A Scorilas, et al.
Cancer|March 15, 1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaM A Levesque, D Katsaros, H Yu, et al.
Pageof 11